{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:19:45Z","timestamp":1757704785929,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,3,1]],"date-time":"1999-03-01T00:00:00Z","timestamp":920246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[1999,3]]},"DOI":"10.1023\/a:1006177619192","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:53:09Z","timestamp":1040518389000},"page":"93-99","source":"Crossref","is-referenced-by-count":2,"title":["Reversal of estrogen\u2010resistance in murine mammary adenocarcinomas"],"prefix":"10.1007","volume":"54","author":[{"given":"Mar\u00eda Fernanda","family":"Montecchia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Molinolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Lanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"200665_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198107023050101","volume":"305","author":"B Fisher","year":"1981","unstructured":"Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, et al.: Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl JMed 305: 1\u20136, 1981","journal-title":"N Engl JMed"},{"key":"200665_CR2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0140-6736(92)90997-H","volume":"339","author":"Early Breast Cancer Trialist Collaboration Group","year":"1992","unstructured":"Early Breast Cancer Trialist Collaboration Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. Lancet 339: 1\u201315, 71\u201385, 1992","journal-title":"Lancet"},{"key":"200665_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01811960","volume":"21","author":"HB Muss","year":"1992","unstructured":"Muss HB: Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res Treat 21: 15\u201326, 1992","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR4","first-page":"15","volume-title":"Growth regulation of cancer","author":"N Brunner","year":"1990","unstructured":"Brunner N, Clarke R, Lippman ME, Dickson RB: Models for studying the progression from hormone-dependency to independency in human breast cancer. In: Lippman ME, Dickson RB (eds) Growth regulation of cancer. New York, Alan Liss, 1990, pp 15\u2013125"},{"key":"200665_CR5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(19890815)64:4<842::AID-CNCR2820640414>3.0.CO;2-C","volume":"64","author":"C Ballare","year":"1989","unstructured":"Ballare C, Bravo AI, Laucella S, Sorin I, Cerdeiro R, Loza J, Souza Martinez F, Guzman N, Mordoh J: DNA synthesis in estrogen receptor-positive human breast cancer takes place preferentially in estrogen receptor-negative cells. Cancer 64: 842\u2013848, 1989","journal-title":"Cancer"},{"key":"200665_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/bjc.1996.2","volume":"73","author":"JFR Robertson","year":"1996","unstructured":"Robertson JFR: Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5\u201312, 1996","journal-title":"Br J Cancer"},{"key":"200665_CR7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00665801","volume":"26","author":"CA Encarnac\u00edon","year":"1993","unstructured":"Encarnac\u00edon CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SAW, Osborne CK: Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat 26: 237\u2013246, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR8","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1016\/S0021-9258(19)50749-9","volume":"267","author":"F Pakdel","year":"1992","unstructured":"Pakdel F, Katzenellenbogen BS: Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination. J Biol Chem 267: 3429\u20133437, 1992","journal-title":"J Biol Chem"},{"key":"200665_CR9","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1073\/pnas.92.10.4206","volume":"92","author":"A Mahfoudi","year":"1995","unstructured":"Mahfoudi A, Roulet E, Dauvois S, Parker MG, Wahli W: Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci USA 92: 4206\u20134210, 1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"200665_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00689687","volume":"26","author":"S Jiang","year":"1992","unstructured":"Jiang S, Parker CJ, Jordan CV: A model to describe how a point mutation of the estrogen receptor alters the structure function relationship of antiestrogens. Breast Cancer Res Treat 26: 139\u2013147, 1992","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR11","first-page":"5934","volume":"53","author":"CG Castles","year":"1993","unstructured":"Castles CG, Fuqua SA, Klotz DM, Hill SM: Expression of a constitutively active estrogen receptor variant in the estrogen receptor negative BT-20 human breast cancer cell line. Cancer Res 53: 5934\u20135939, 1993","journal-title":"Cancer Res"},{"key":"200665_CR12","first-page":"1556","volume":"56","author":"D Rea","year":"1996","unstructured":"Rea D, Parker MJ: Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res 56:1556\u20131563, 1996","journal-title":"Cancer Res"},{"key":"200665_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0960-0760(97)00034-4","volume":"62","author":"DA Tonetti","year":"1997","unstructured":"Tonetti DA, Jordan VC: The role of estrogen mutations in tamoxifen-stimulated breast cancer. J Steroid Biochem Molec Biol 62: 119\u2013128, 1997","journal-title":"J Steroid Biochem Molec Biol"},{"key":"200665_CR14","first-page":"288","volume":"55","author":"AAI Daffada","year":"1995","unstructured":"Daffada AAI, Johnston SRD, Smith IE, Detre S, King N, Dowsett M: Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor\/pS2 status in human breast cancer. Cancer Res 55: 288\u2013293, 1995","journal-title":"Cancer Res"},{"key":"200665_CR15","first-page":"349","volume":"54","author":"PS Karnik","year":"1994","unstructured":"Karnik PS, Kulkarni S, Liu XP, Budd GT, Bukowski RM: Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 54: 349\u2013353, 1994","journal-title":"Cancer Res"},{"key":"200665_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF01803784","volume":"38","author":"R Lupu","year":"1996","unstructured":"Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D, Tang C: The significance of heregulin in breast cancer tumor progression and drug resistance. Breast Cancer Res Treat 38: 57\u201366, 1996","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1005865812918","volume":"45","author":"M Reiss","year":"1997","unstructured":"Reiss M, Barcellos-Hoff MH: Transforming growth factor \u03b2 in breast cancer: aworking hypothesis. Breast Cancer Res Treat 45: 81\u201395, 1997","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR18","first-page":"279","volume":"2","author":"DJ Zhou","year":"1988","unstructured":"Zhou DJ, Casey G, Cline MJ: Amplification of human int-2 in breast cancers and squamous carcinomas. Oncogene 2:279\u2013282, 1988","journal-title":"Oncogene"},{"key":"200665_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1043-2760(96)00127-0","volume":"7","author":"R Clarke","year":"1996","unstructured":"Clarke R, Br\u00fcnner N: Acquired estrogen independence and antiestrogen resistance in breast cancer. Estrogen receptordriven phenotypes? Trends Endocrinol Metab 7: 291\u2013301,1996","journal-title":"Trends Endocrinol Metab"},{"key":"200665_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00683192","volume":"27","author":"DP Edwards","year":"1993","unstructured":"Edwards DP, Weigel NL, Nordeen SK, Beck CA: Modulators of cellular protein phosphorylation after the transactivation function of human progesterone receptor and the biological activity of progesterone antagonists. Breast Cancer Res Treat 27: 41\u201356, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR21","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0960-0760(97)80026-X","volume":"61","author":"H Sasano","year":"1997","unstructured":"Sasano H, Ozaki M: Aromatase expression and its localization in human breast cancer. J Steroid Biochem Mol Biol 61: 293\u2013298, 1997","journal-title":"J Steroid Biochem Mol Biol"},{"key":"200665_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF00666205","volume":"32","author":"CK Osborne","year":"1994","unstructured":"Osborne CK, Fuqua SAW: Mechanisms of tamoxifen resistance. Breast Cancer Res Treat 32: 49\u201355, 1994","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<461::AID-IJC1>3.0.CO;2-Y","volume":"73","author":"MM Burger","year":"1997","unstructured":"Burger MM, Moses HL, UICC Study Group on Basic and Clinical Cancer Research: Mechanisms of growth factor and hormone insensitivity. Int J Cancer 73: 461\u2013463, 1997","journal-title":"Int J Cancer"},{"key":"200665_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0304-3835(86)90027-3","volume":"33","author":"C Lanari","year":"1986","unstructured":"Lanari C, Molinolo AA, Pasqualini CD: Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB\/c mice. Cancer Letters 33: 215\u2013223, 1986","journal-title":"Cancer Letters"},{"key":"200665_CR25","first-page":"1341","volume":"79","author":"AA Molinolo","year":"1987","unstructured":"Molinolo AA, Lanari C, Charreau EH, Sanjuan N, Pasqualini CD: Mouse mammary tumors induced by medroxyprogesterone acetate: immunochemistry and hormonal receptors. J Natl Cancer Inst 79: 1341\u20131350, 1987","journal-title":"J Natl Cancer Inst"},{"key":"200665_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00666353","volume":"28","author":"E Kordon","year":"1993","unstructured":"Kordon E, Molinolo AA, Pasqualini CD, Charreau EH, Pazos P, Dran G, Lanari C: Progesterone induction of mammary carcinomas in BALB\/c female mice. Correlation between hormone dependence and morphology. Breast Cancer Res Treat 28: 29\u201339, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.2910590210","volume":"59","author":"E Kordon","year":"1994","unstructured":"Kordon E, Guerra F, Molinolo AA, Elizalde P, Charreau EH, Pasqualini CD, Montecchia MF, Lanari C: Effect of sialoadenectomy on medroxyprogesterone acetate (MPA)-induced mammary carcinogenesis in BALB\/c mice. Int J Cancer 59: 196\u2013203, 1994","journal-title":"Int J Cancer"},{"key":"200665_CR28","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ijc.2910490617","volume":"49","author":"E Kordon","year":"1991","unstructured":"Kordon E, Lanari C, Molinolo AA, Elizalde P, Charreau EH, Pasqualini CD: Estrogen inhibition of MPA-induced mouse mammary tumor transplants. Int J Cancer 49: 900\u2013905, 1991","journal-title":"Int J Cancer"},{"key":"200665_CR29","first-page":"430","volume-title":"Progress in Cancer Res and Therapy, Vol 35. Hormones and Cancer","author":"PG Satyaswaroop","year":"1988","unstructured":"Satyaswaroop PG, Sivarajah A, Zaino RJ, Mortel R: Hormonal control of growth of human endometrial carcinoma in the nude mouse model. In: Bresciani F, King RJB, Lippman ME, Raynaud JP (eds) Progress in Cancer Res and Therapy, Vol 35. Hormones and Cancer 3, Raven Press, New York, 1988, pp 430\u2013435"},{"key":"200665_CR30","first-page":"5183","volume":"48","author":"MM Gottardis","year":"1988","unstructured":"Gottardis MM, Jordan VC: Development of tamoxifenstimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res 48:5183\u20135187, 1988","journal-title":"Cancer Res"},{"key":"200665_CR31","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/83.20.1477","volume":"83","author":"KC Osborne","year":"1991","unstructured":"Osborne KC, Coronado C, Allred K, Wiebe V, DeGregorio M: Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J Natl Cancer Inst 83: 1477\u20131482,1991","journal-title":"J Natl Cancer Inst"},{"key":"200665_CR32","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ijc.2910400616","volume":"40","author":"PD Darbre","year":"1987","unstructured":"Darbre PD, King RJB: Interaction of different steroid hormones during progression of tumour cells to steroid autonomy. Int J Cancer 40: 802\u2013806, 1987","journal-title":"Int J Cancer"},{"key":"200665_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00666162","volume":"31","author":"S Paik","year":"1994","unstructured":"Paik S, Hartmann DP, Dickson RB, Lippmann ME: Antiestrogen resistance in ER positive breast cancer cells. Breast Cancer Res Treat 31: 301\u2013307, 1994","journal-title":"Breast Cancer Res Treat"},{"key":"200665_CR34","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0021-9258(17)34875-5","volume":"253","author":"FW Alt","year":"1978","unstructured":"Alt FW, Kellems RE, Bertino JR, Schimke RT: Selective multiplication of dihydrofolate reductase genes in methotrexate-resistant variants of cultured mouse cells. J Biol Chem 253: 1357\u20131370, 1978","journal-title":"J Biol Chem"},{"key":"200665_CR35","first-page":"1349","volume":"296","author":"C Markopoulos","year":"1988","unstructured":"Markopoulos C, Berger U, Wilson P, Gazet JC, Coombes RC: Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br JMed 296: 1349\u20131351, 1988","journal-title":"Br JMed"},{"key":"200665_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/07357908809077024","volume":"6","author":"DM Axelrod","year":"1988","unstructured":"Axelrod DM, Menendez-Botet CJ, Kinne DW, Osborne MP: Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of menses. Cancer Invest 6: 7\u201314, 1988","journal-title":"Cancer Invest"},{"key":"200665_CR37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01805764","volume":"10","author":"DA Weimer","year":"1987","unstructured":"Weimer DA, Donegan WL:Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle. Breast Cancer Res Treat 10: 273\u2013278 1987","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006177619192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006177619192\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006177619192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006177619192.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:32:09Z","timestamp":1750480329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006177619192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,3]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,3]]}},"alternative-id":["200665"],"URL":"https:\/\/doi.org\/10.1023\/a:1006177619192","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[1999,3]]}}}